ESCMID
As demonstrated during the COVID-19 pandemic and in newer research, saliva holds promise as an alternative sample type for PCR-based infectious disease testing.
ESCMID Global Panelists Underscore Role of Rapid Dx Testing in Antimicrobial Resistance Battle
Premium
In a BioMérieux-sponsored symposium, economist Lord Jim O'Neill revisited a 2016 report on AMR while experts discussed the use of rapid testing tools such as those offered by the French company.
Spanish Startup DeepUll Unveils MDx Platform, Direct-From-Blood Sepsis Assay at ESCMID Global
Premium
DeepUll showcased its UllCore platform and BSI Test, a one-hour multiplex PCR assay targeting 95 percent of sepsis-causing pathogens and multiple antibiotic resistance genes.